<DOC>
	<DOCNO>NCT01429753</DOCNO>
	<brief_summary>Cardiac resynchronisation therapy ( CRT ) establish treatment improve symptom patient congestive heart failure ( CHF ) leave ventricular ( LV ) pacing . CRT help improve LV function patient heart failure region myocardium compromise electromechanical dyssynchrony identify effectively stimulate . There still remain , however , significant rate 30 % patient respond treatment . Reasons lack benefit related inability identify effectively stimulate region myocardium , compromise electromechanical dyssynchrony . The investigator hypothesize use cardiac MR 3D echo identify scar , reconstruct coronary sinus anatomy , determine site late LV activation , investigator find best place implant leave ventricular lead . By avoid scar pace site late activation , investigator believe investigator reduce dyssynchrony thus improve overall heart function . The researcher thus aim increase proportion people respond treatment . The researcher also believe procedure may streamline reduce procedure duration , radiation dose dose iodinate contrast medium .</brief_summary>
	<brief_title>PRISM Cardiac Resynchronisation Therapy ( CRT ) Randomised Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>&gt; 18yrs age Standard indication CRT=P CRT=D accord NICE criterion ( Clinical symptom heart failure despite medical therapy , broad QRS &gt; 120ms significant LV dysfunction LEF &lt; 35 % ) Stable optimal medical therapy least 3 month No exclusion pace /ICD Ischaemic nonischaemic aetiology Any contraindication pace /ICD implant Contraindication MR scan Claustrophobia Significant renal impairment ( estimate GFR &lt; 30 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Cardiac resychronisation therapy</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Imaging guide LV lead placement</keyword>
</DOC>